NFE2L2 and cancer: Though the constitutively activated Nrf2 and subsequent overexpression of antioxidant and related stress response proteins can confer survival advantage and resistance to anticancer therapy in cancer cells, this does not necessarily exclude the benefit of Nrf2 inducers in normal cells.